Telluride Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Telluride Asset Management’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$243K	Buy	+3,484	New	+$237K	0.21%	168

Other funds holding CBST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Telluride Asset Management's CBST Position: Q2 2014 in Review

Telluride Asset Management opened a new position in CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014: 3,484 shares worth $243K. The stake represents 0.21% of the portfolio and ranks #168 among its holdings.

270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

Telluride Asset Management held 3,484 shares of CUBIST PHARMACEUTICALS INC worth $243K as of Q2 2014.
CUBIST PHARMACEUTICALS INC was a new Telluride Asset Management position in Q2 2014.
CUBIST PHARMACEUTICALS INC made up 0.21% of Telluride Asset Management's portfolio in Q2 2014, its #168 holding.
270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Telluride Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.